deferoxamine has been researched along with cysteine in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (22.22) | 18.7374 |
| 1990's | 13 (48.15) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Muller, S; Olitzki, AL | 1 |
| Brunk, UT; Gao, G; Zhang, H | 1 |
| Constable, A; Gray, NK; Hentze, MW; Quick, S | 1 |
| Beckman, JS; Bush, KM; Freeman, BA; Radi, R | 1 |
| Brunk, UT; Zdolsek, JM; Zhang, H | 1 |
| Brown, PC; Chen, Q; Jones, TW; Stevens, JL | 1 |
| Corbella, J; Domingo, JL; Gómez, M; Llobet, JM | 1 |
| MacDonald, RA; MacSween, RN; Pechet, GS | 1 |
| Berneis, K; Kofler, M | 1 |
| Brancato, G; Cardinale, A; De Simone, GF | 1 |
| Drummond, GS; Kappas, A | 1 |
| Carr, BI; Dowd, P; Finn, F; Kar, S; Kerns, J; Naganathan, S; Nishikawa, Y; Wang, M; Zheng, ZB | 1 |
| Davis, JW; Petry, TW | 1 |
| de Bont, HJ; Mulder, GJ; Nagelkerke, JF; van de Water, B; Zoeteweij, JP | 1 |
| Haile, D; Klausner, RD; Philpott, CC; Rouault, TA | 1 |
| Sagripanti, JL; Toyokuni, S | 1 |
| Brunk, UT; Zhang, H | 1 |
| An, W; Corrales, FJ; Mato, JM; Mingorance, J; Ruiz, F; Sánchez-Góngora, E | 1 |
| Bunn, HF; Goldberg, MA; Gu, J; Huang, LE; Willmore, WG | 1 |
| Aleryani, S; Kostka, P; Skiles, EH; Sorenson, E; Xu, B | 1 |
| Bai, C; Chakrabarti, SK; Subramanian, KS | 1 |
| González, C; Latorre, R; Lissi, E; Soto, MA; Vergara, C | 1 |
| Chiou, TJ; Chu, ST; Tzeng, WF | 1 |
| Gu, J; Lewis, RS | 1 |
| Alvarez, LD; Clarêncio, J; Costa, MF; Costa, SL; El-Bachá, RS; Lima, RM | 1 |
| Qiao, C; Wang, L; Xiao, SH; Xue, J | 1 |
1 review(s) available for deferoxamine and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
26 other study(ies) available for deferoxamine and cysteine
| Article | Year |
|---|---|
Further investigations on M. leprae. Growth promotion and inhibition by organic substances and observations on antagonistic and syntergistic effects.
Topics: Cysteine; Deferoxamine; Dimethyl Sulfoxide; Drug Antagonism; Drug Synergism; Glutamates; Glutamine; Histidine; Mycobacterium leprae; Purines; Pyrimidines; Tryptophan | 1975 |
Extracellular reduction of alloxan results in oxygen radical-mediated attack on plasma and lysosomal membranes.
Topics: Acridine Orange; Alloxan; Animals; Catalase; Cell Membrane; Cell Membrane Permeability; Cysteine; Deferoxamine; Free Radicals; In Vitro Techniques; Intracellular Membranes; Kinetics; Lysosomes; Mice; Microscopy, Fluorescence; Mitochondria; Oxidation-Reduction; Oxygen; Oxygen Consumption; Superoxide Dismutase; Tumor Cells, Cultured | 1992 |
Modulation of the RNA-binding activity of a regulatory protein by iron in vitro: switching between enzymatic and genetic function?
Topics: Base Sequence; Chromatography, Affinity; Cysteine; Deferoxamine; Female; Humans; Iron; Iron-Regulatory Proteins; Kinetics; Molecular Sequence Data; Placenta; Pregnancy; RNA Probes; RNA-Binding Proteins; RNA, Messenger; RNA, Small Nuclear; Templates, Genetic; Transcription, Genetic | 1992 |
Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.
Topics: Animals; Arsenic; Arsenites; Borohydrides; Cattle; Chelating Agents; Cyanides; Cysteine; Deferoxamine; Disulfides; Free Radicals; Hydrogen Peroxide; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Nitric Oxide; Oxidation-Reduction; Serum Albumin, Bovine; Spectrophotometry, Ultraviolet; Sulfhydryl Compounds; Superoxides | 1991 |
Effects of alloxan and reducing agents on macrophages in culture.
Topics: Alloxan; Animals; Ascorbic Acid; Catalase; Cell Death; Cell Line; Cell Survival; Cysteine; Deferoxamine; Free Radicals; Macrophages; Mice; Oxygen Consumption; Superoxide Dismutase | 1991 |
The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells. Covalent binding leads to thiol depletion and lipid peroxidation.
Topics: Animals; Antioxidants; Carbon-Sulfur Lyases; Cell Line; Cell Survival; Cysteine; Deferoxamine; Dithiothreitol; Epithelium; In Vitro Techniques; Kidney; Lipid Peroxides; Lyases; Phenylenediamines; Rats; Sulfhydryl Compounds | 1990 |
Acute aluminium intoxication: a study of the efficacy of several antidotal treatments in mice.
Topics: Aluminum; Animals; Chelating Agents; Citrates; Citric Acid; Cysteine; Deferoxamine; Lethal Dose 50; Male; Mice; Sodium Salicylate; Tissue Distribution | 1986 |
Iron metabolism by reticuloendothelial cells in vitro. Physical and chemical conditions, lipotrope deficiency, and acute inflammation.
Topics: Animals; Ascorbic Acid; Cobalt; Copper; Cysteine; Dactinomycin; Deferoxamine; Dinitrophenols; Edetic Acid; Fatty Liver; Fluorides; Fructose; Glucose; Glutathione; Hemochromatosis; Inflammation; Iodoacetates; Iron; Lipotropic Agents; Liver Cirrhosis; Lung; Macrophages; Microscopy, Electron; Potassium Permanganate; Protein Biosynthesis; Puromycin; Rabbits; RNA; Saponins; Sucrose; Surface-Active Agents; Transferrin; Trypsin | 1969 |
The degradation of deoxyribonucleic acid by L-cysteine and the promoting effect of metal chelating agents and of catalase.
Topics: Catalase; Cysteamine; Cysteine; Deferoxamine; DNA; Edetic Acid; Oxidation-Reduction; Viscosity | 1964 |
[Elimination of radiomercury by the kidneys: effect of drugs with a competitive action with chlormerodrin-Hg203].
Topics: Animals; Chlormerodrin; Cysteamine; Cysteine; Deferoxamine; Dimercaprol; Edetic Acid; Kidney; Mercury Isotopes; Rabbits; Thioctic Acid | 1967 |
Potent heme-degrading action of antimony and antimony-containing parasiticidal agents.
Topics: 5-Aminolevulinate Synthetase; Animals; Anti-Infective Agents; Antimony; Cobalt; Cysteine; Deferoxamine; Dose-Response Relationship, Drug; Heme; Heme Oxygenase (Decyclizing); Kidney; Liver; Male; Rats; Time Factors; Zinc | 1981 |
Growth inhibition of hepatoma cells induced by vitamin K and its analogs.
Topics: Amino Acid Sequence; Blotting, Northern; Carcinoma, Hepatocellular; Catalase; Cell Division; Cell Line; Cysteine; Deferoxamine; DNA Damage; Gene Expression; Genes, myc; Glutathione; Humans; Ligases; Liver Neoplasms; Molecular Sequence Data; Molecular Structure; Oligopeptides; Structure-Activity Relationship; Tumor Cells, Cultured; Vitamin K | 1995 |
Inhibition of S-(1,2-dichlorovinyl)-L-cysteine-induced lipid peroxidation by antioxidants in rabbit renal cortical slices: dissociation of lipid peroxidation and toxicity.
Topics: Aminooxyacetic Acid; Animals; Antioxidants; Chromans; Cysteine; Deferoxamine; DNA; In Vitro Techniques; Kidney Cortex; Lipid Peroxidation; Male; Piperazines; Potassium; Pregnatrienes; Rabbits; Thiobarbituric Acid Reactive Substances | 1994 |
Role of mitochondrial Ca2+ in the oxidative stress-induced dissipation of the mitochondrial membrane potential. Studies in isolated proximal tubular cells using the nephrotoxin 1,2-dichlorovinyl-L-cysteine.
Topics: Animals; Antioxidants; Benzene Derivatives; Calcium; Cysteine; Deferoxamine; Egtazic Acid; Flow Cytometry; In Vitro Techniques; Intracellular Membranes; Kidney Tubules, Proximal; Kinetics; Male; Membrane Potentials; Mitochondria; Oxygen; Phenylenediamines; Rats; Rats, Wistar | 1994 |
Modification of a free Fe-S cluster cysteine residue in the active iron-responsive element-binding protein prevents RNA binding.
Topics: Amino Acid Sequence; Animals; Cell Line; Cysteine; Cytosol; Deferoxamine; Ethylmaleimide; Fibroblasts; Hemin; Iron-Regulatory Proteins; Iron-Sulfur Proteins; Mice; Polymerase Chain Reaction; Recombinant Proteins; RNA-Binding Proteins; RNA, Messenger; Serine | 1993 |
Induction of oxidative single- and double-strand breaks in DNA by ferric citrate.
Topics: Ascorbic Acid; Catalase; Cysteine; Deferoxamine; DNA Damage; DNA, Superhelical; Ferric Compounds; Free Radical Scavengers; Hydrogen Peroxide; Hydrogen-Ion Concentration; Osmolar Concentration; Plasmids; Superoxides | 1993 |
Alloxan cytotoxicity is highly potentiated by plasma membrane- and lysosomal-associated iron--a study on a model system of cultured J-774 cells.
Topics: Alloxan; Animals; Cell Line; Cell Membrane; Cell Membrane Permeability; Cell Survival; Chlorides; Cysteine; Deferoxamine; Ferric Compounds; Hydrogen Peroxide; Kinetics; Lymphoma, Large B-Cell, Diffuse; Lysosomes; Mice; Models, Biological; Time Factors; Tumor Cells, Cultured | 1993 |
Interaction of liver methionine adenosyltransferase with hydroxyl radical.
Topics: Amino Acid Substitution; Animals; Binding Sites; CHO Cells; Cricetinae; Cysteine; Deferoxamine; Glutathione; Hydrogen Peroxide; Hydroxyl Radical; Kinetics; Liver; Methionine Adenosyltransferase; Models, Structural; Mutagenesis, Site-Directed; Protein Conformation; Rats; Recombinant Proteins; Transfection | 1997 |
Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling.
Topics: Aryl Hydrocarbon Receptor Nuclear Translocator; Carbon Monoxide; Cell Hypoxia; Cell Line; Cobalt; Cyclic GMP; Cysteine; Deferoxamine; DNA-Binding Proteins; Erythropoietin; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Nitric Oxide; Nitroprusside; Nuclear Proteins; Oxygen; Receptors, Aryl Hydrocarbon; RNA, Messenger; Transcription Factors; Transcriptional Activation; Transfection | 1999 |
Role of redox-active iron ions in the decomposition of S-nitrosocysteine in subcellular fractions of porcine aorta.
Topics: Animals; Aorta; Chelating Agents; Cysteine; Cytosol; Deferoxamine; Dose-Response Relationship, Drug; Ions; Iron; Iron Chelating Agents; Kinetics; L-Lactate Dehydrogenase; Magnesium; Models, Chemical; Muscle, Smooth, Vascular; Nitroso Compounds; Pentetic Acid; Phenanthrolines; Pyridines; S-Nitrosothiols; Swine; Time Factors | 2000 |
DNA-protein crosslinks induced by nickel compounds in isolated rat lymphocytes: role of reactive oxygen species and specific amino acids.
Topics: Acetates; Animals; Cross-Linking Reagents; Cysteine; Deferoxamine; DNA; DNA Damage; Dose-Response Relationship, Drug; Free Radical Scavengers; Histidine; Lymphocytes; Magnesium; Nickel; Occupational Exposure; Organometallic Compounds; Oxidative Stress; Proteins; Rats; Reactive Oxygen Species | 2001 |
Ca(2+)-activated K+ channel inhibition by reactive oxygen species.
Topics: Animals; Calcium; Cysteine; Deferoxamine; Dithiothreitol; Female; Humans; Hydrogen Peroxide; Hydroxyl Radical; Ion Channel Gating; Iron Chelating Agents; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Large-Conductance Calcium-Activated Potassium Channels; Lipid Bilayers; Muscle, Skeletal; Oocytes; Oxidants; Patch-Clamp Techniques; Potassium Channels, Calcium-Activated; Reactive Oxygen Species; Xenopus laevis | 2002 |
Protection of cells from menadione-induced apoptosis by inhibition of lipid peroxidation.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Cysteine; Deferoxamine; Drug Interactions; Flow Cytometry; Glutathione; Iron Chelating Agents; Lipid Peroxidation; Lipid Peroxides; Mice; Muscle, Skeletal; Myoblasts; Necrosis; Oxidative Stress; Ploidies; Reactive Oxygen Species; Vitamin K 3 | 2003 |
Effect of pH and metal ions on the decomposition rate of S-nitrosocysteine.
Topics: Buffers; Cadmium; Chelating Agents; Copper; Cysteine; Deferoxamine; Drug Stability; Hydrogen-Ion Concentration; Ions; Iron; Kinetics; Lead; Mercury; Metals, Heavy; S-Nitrosothiols; Spectrophotometry, Ultraviolet | 2007 |
Cytotoxic effects of catechol to neuroblastoma N2a cells.
Topics: Animals; Antioxidants; Apoptosis; Ascorbic Acid; Catechols; Cell Line, Tumor; Cell Survival; Curcumin; Cysteine; Cytotoxins; Deferoxamine; Glutathione; Mice; Neuroblastoma; NF-kappa B; Reactive Oxygen Species; Sesquiterpenes; Superoxide Dismutase | 2008 |
Mefloquine in combination with hemin causes severe damage to adult Schistosoma japonicum in vitro.
Topics: 2,2'-Dipyridyl; Animals; Anthelmintics; Ascorbic Acid; Cysteine; Deferiprone; Deferoxamine; Drug Synergism; Drug Therapy, Combination; Ferric Compounds; Ferrous Compounds; Glutathione; Hemin; Inhibitory Concentration 50; Iron Chelating Agents; Mefloquine; Protoporphyrins; Pyridones; Schistosoma japonicum | 2014 |